Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 11, 2026 08:30 ET | Source: Alpha Tau Medical Ltd.

Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control

Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Trial and Add Two U.S. Sites; Early Interim Results Showed 100% Local Disease Control
May 18, 2026 16:01 ET | Source: Alpha Tau Medical Ltd.

Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update

Alpha Tau Announces First Quarter 2026 Financial Results and Provides Corporate Update
August 29, 2023 07:00 ET | Source: OKYO Pharma LTD

OKYO Pharma Limited Regains Compliance with Nasdaq Listing Minimum Market Value Rule

NEW YORK and LONDON, Aug. 29, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) ("OKYO" or the "Company"), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to...